Alpha 1 antitrypsin deficiency prevalence measured by genetic testing with salivary swab in patients with chronic airway obstruction
W. Giron Matute (Madrid, Spain), M. Hernandez Yañez (Madrid, Spain), R. Rojas Moreno-Tomé (Madrid, Spain), M. Gallardo Bermejo (Madrid, Spain), A. Gómez Sacristán (Madrid, Spain), B. Escalonilla Bautista (Madrid, Spain), M. Suarez Rubio (Madrid, Spain), J. García López (Madrid, Spain), L. Puente Maestu (Madrid, Spain)
Source: Virtual Congress 2020 – Challenges and updates in nursing care around the world
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
W. Giron Matute (Madrid, Spain), M. Hernandez Yañez (Madrid, Spain), R. Rojas Moreno-Tomé (Madrid, Spain), M. Gallardo Bermejo (Madrid, Spain), A. Gómez Sacristán (Madrid, Spain), B. Escalonilla Bautista (Madrid, Spain), M. Suarez Rubio (Madrid, Spain), J. García López (Madrid, Spain), L. Puente Maestu (Madrid, Spain). Alpha 1 antitrypsin deficiency prevalence measured by genetic testing with salivary swab in patients with chronic airway obstruction. 585
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: